2025
SJR Q1
JCR Q1 · 3,4
OA
11 matched articles
SSCI
Journal detail
Health Economics Review
- Publisher
- BioMed Central Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
21911991
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,926
- Quartile Q1
- H-Index 48
- Cites/doc 3,12
- Docs (3y) 218
- Cites (3y) 760
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 3,4
- 5Y JIF 3,6
- JCI 0,9
WoS indexes
- SSCI
Subject classification
Categories (SJR)
- Health Policy Q1
Areas
- Medicine
WoS categories
- Economics | Health Policy & Services
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 0,926 | 3,4 | 3,6 | 0,9 | Q1 | 48 |
| 2024 | Q1 | Q1 | 0,915 | 3,3 | 3 | 0,89 | Q2 | 41 |
| 2023 | Q2 | Q1 | 0,8 | 2,7 | 2,8 | 0,83 | Q2 | 41 |
| 2022 | Q2 | Q2 | 0,836 | 2,4 | 2,8 | 0,69 | Q2 | 41 |
| 2021 | Q2 | Q2 | 0,535 | 2,1 | 2,5 | 0,7 | Q2 | 41 |
| 2020 | Q2 | Q2 | 0,778 | 2,3 | 2,5 | 0,74 | Q2 | 41 |
| 2019 | Q2 | Q2 | 0,724 | 1,5 | — | 0,73 | Q2 | 41 |
| 2018 | — | Q2 | — | 1,4 | — | 0,72 | Q2 | — |
| 2017 | Q2 | Q2 | 0,71 | 1,5 | — | 0,68 | Q2 | 41 |
| 2016 | Q2 | — | 0,469 | — | — | — | — | 41 |
| 2015 | Q2 | — | 0,659 | — | — | — | — | 41 |
| 2014 | Q2 | — | 0,561 | — | — | — | — | 41 |
| 2013 | Q2 | — | 0,392 | — | — | — | — | 41 |
| 2012 | Q4 | — | 0,116 | — | — | — | — | 41 |
| 2011 | — | — | — | — | — | — | — | 41 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ECONOMICS | SSCI | Q1 | Q1 | 115/626 |
| 2025 | HEALTH POLICY & SERVICES | SSCI | Q1 | Q2 | 23/125 |
| 2024 | ECONOMICS | SSCI | Q1 | Q2 | 104/620 |
| 2024 | HEALTH POLICY & SERVICES | SSCI | Q1 | Q2 | 15/125 |
| 2023 | ECONOMICS | SSCI | Q1 | Q2 | 140/600 |
| 2023 | HEALTH POLICY & SERVICES | SSCI | Q2 | Q2 | 38/118 |
| 2022 | ECONOMICS | SSCI | Q2 | Q2 | 161/380 |
| 2022 | HEALTH POLICY & SERVICES | SSCI | Q3 | Q3 | 55/87 |
| 2021 | ECONOMICS | SSCI | Q2 | Q2 | 188/381 |
| 2021 | HEALTH POLICY & SERVICES | SSCI | Q3 | Q3 | 64/88 |
| 2020 | ECONOMICS | SSCI | Q2 | Q2 | 145/376 |
| 2020 | HEALTH POLICY & SERVICES | SSCI | Q3 | Q3 | 54/88 |
| 2019 | ECONOMICS | SSCI | Q2 | Q2 | 169/373 |
| 2019 | HEALTH POLICY & SERVICES | SSCI | Q3 | Q2 | 60/87 |
| 2018 | ECONOMICS | SSCI | Q2 | Q2 | 161/363 |
| 2018 | HEALTH POLICY & SERVICES | SSCI | Q3 | Q3 | 60/82 |
| 2017 | ECONOMICS | SSCI | Q2 | Q2 | 127/353 |
| 2017 | HEALTH POLICY & SERVICES | SSCI | Q3 | Q3 | 51/79 |